Updated results from a phase I trial of CAR-T cell therapy for r/rMM
Updated results from a phase I trial of CAR-T cell therapy for r/rMM
Ribosomal lesions promote oncogenic mutagenesis
Interim results of RELEVANCE trial in follicular lymphoma
Disease control in advanced Hodgkin lymphoma
Rituximab in combination therapies for FL: Interim results
Mapping 3D genome dynamics in B cells
Novel fusion proteins to target PD-L1 in HPV associated cancers
Phase I study results of M7824 for patients with HPV associated cancers
Early results from a 3rd gen EGFR-TKI in advanced NSCLC
Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer
First-in-human phase 1 study of TAK-931 for solid tumours
Development of blood tests for early lung cancer